Through Executive Decree No. 451, issued on June 9, 2022, the
Regulations to the Public Procurement Law were amended. The
amendment covers the provisions applicable to the acquisition of
medicines and strategic health goods for outpatient care
(“Products“) by the Public Health
Network (“PHN“) to private pharmacies
qualified by the national health authority
(“Pharmacies“).
The main aspects of this amendment are:
- The prices of the Products, which the PHN shall pay to the
Pharmacies, shall be those provided in the electronic catalog. In
addition, the PHN shall pay each Pharmacy an additional amount for
“operating costs” to be analyzed and fixed by
the National Health Authority
(“NHA“).
